Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.
about
A Survey of Therapeutic Effects of Artemisia capillaris in Liver DiseasesCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesInhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer TherapiesExposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes)Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis inductionPPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseEvaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.Japanese encephalitis virus nonstructural protein NS5 interacts with mitochondrial trifunctional protein and impairs fatty acid β-oxidation.Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsMetabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control studyEfficacy of zinc oxide nanoparticles in attenuating pancreatic damage in a rat model of streptozotocin-induced diabetes.Hepatic Responses of Juvenile Fundulus heteroclitus from Pollution-adapted and Nonadapted Populations Exposed to Elizabeth River Sediment ExtractCancer metabolism: fatty acid oxidation in the limelight.Evaluation of drug-induced injury and human response in precision-cut tissue slices.The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats.Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target.CD36 in chronic kidney disease: novel insights and therapeutic opportunities.Liver Effects of Clinical Drugs Differentiated in Human Liver Slices.Acute toxicity of commercial atrazine in Piaractus mesopotamicus: Histopathological, ultrastructural, molecular, and genotoxic evaluation.Epidermal cells help coordinate leukocyte migration during inflammation through fatty acid-fuelled matrix metalloproteinase production.Pluripotency transcription factors and Metabolic reprogramming of mitochondria in tumor-initiating stem-like cells.Blocking fatty acid-fueled mROS production within macrophages alleviates acute gouty inflammation.Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells.The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations.
P2860
Q26781118-7CF634C7-8E32-40D6-B471-35E6793C1280Q26823118-719B67B0-21F1-4782-AD16-04EF0F3E6902Q28393381-82B678CC-3F65-42E8-9854-5B60F5F8A312Q30494047-CED965C5-9D30-4C64-BBF6-AE797B0D40F6Q33561797-6184AC31-A6E8-486A-8B8C-722B3A49A93EQ33734125-23C6027E-26FB-4CA2-867D-A4EBF41206C1Q34932672-ACD06D18-9734-4AF8-A3A4-F4AC69CAFE87Q35224602-38479594-E8E8-4D0C-AE73-A3B07DBBEA7DQ35603973-F1D506F0-F0C1-4C96-9F72-D39A46CFC836Q35756786-7328E2B0-C6E4-49B3-A7C2-064E2E0B2A21Q36202355-BCADF6B4-555D-4503-B0B4-96165238FAABQ37017247-93C60F41-13EB-4E07-B7BA-A4BB276667CCQ37155867-E06488D1-C276-4B4F-9ED5-FAC62F0A1626Q38055199-CF52A2EF-4E89-4116-87EB-C463C06DAD85Q38468908-D920FE74-590C-42EA-92B5-DF85484C2B43Q38883310-976EDA85-EF84-4349-9BCF-8AF5785156A2Q40232460-697EC5FB-0B9C-4DE8-AD77-EA82A57BB7D2Q41935783-D0890107-4836-4962-BB19-F76E109103F9Q41951728-7980EA5A-2819-4925-937A-F848224CB914Q44730756-431E15A9-FF12-4FAA-A2CD-09ADFE515BBEQ46891288-C744AD9D-059D-40E1-9D87-9C19E4FBB9C9Q47563636-162BEAD2-580A-4388-B6F1-3884A0BC0B4EQ52628078-3FDA2A1E-AA01-401C-A281-B84FCEA1425CQ52716329-5726F57A-7183-4606-ABFE-C74033CDA206Q55100676-32352F09-671B-4609-8209-29A455FCF892
P2860
Characterization of hepatic mitochondrial injury induced by fatty acid oxidation inhibitors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@en
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@nl
type
label
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@en
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@nl
prefLabel
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@en
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@nl
P2860
P356
P1476
Characterization of hepatic mi ...... tty acid oxidation inhibitors.
@en
P2093
Alison E M Vickers
P2860
P356
10.1177/0192623308329285
P407
P577
2009-01-01T00:00:00Z